Loading...
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer
The acquisition of resistance is a major obstacle to the clinical use of platinum drugs for ovarian cancer treatment. Increase of DNA damage response is one of major mechanisms contributing to platinum-resistance. However, how DNA damage response is regulated in platinum-resistant ovarian cancer cel...
Na minha lista:
| Udgivet i: | Cancer Lett |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7474466/ https://ncbi.nlm.nih.gov/pubmed/29704517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2018.04.029 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|